Integrated Immunovirological Profiling Validates Plasma SARS-CoV-2 RNA as an Early Predictor of COVID-19 Mortality

To identify early predictors of mortality within 60 days of symptom onset, researchers performed immunovirological assessments on plasma from 279 individuals.